C23H20F3N5O2S2.CH4O3S
Neat
519.56. 96.10
+5°C
Room Temperature
Dabrafenib mesylate; 1195768-06-9; Taflinar; UNII-B6DC89I63E; GSK 2118436B; GSK-2118436B; Dabrafenib methanesulfonate; GSK2118436B; B6DC89I63E; dabrafenib monomesylate; GSK-2118436B MESYLATE; GSK2118436 Methane sulfonate salt; GSK2118436B, methane sulfonate salt; GSK-2118436 METHANESULFONATE SALT; Benzenesulfonamide, N-[3-[5-(2-amino-4-pyrimidinyl)-2-(1, 1-dimethylethyl)-4-thiazolyl]-2-fluorophenyl]-2, 6-difluoro-, methanesulfonate (1:1); GSK-2118436B METHANESULFONATE SALT; CHEBI:75048; DTXSID70152500; BENZENESULFONAMIDE, N-(3-(5-(2-AMINO-4-PYRIMIDINYL)-2-(1, 1-DIMETHYLETHYL)-4-THIAZOLYL)-2-FLUOROPHENYL)-2, 6-DIFLUORO-, METHANESULFONATE (1:1); N-(3-(5-(2-aminopyrimidin-4-yl)-2-tert-butyl-1, 3-thiazol-4-yl)-2-fluorophenyl)-2 and 6-difluorobenzenesulfonamide methanesulfonate
N-[3-[5-(2-aminopyrimidin-4-yl)-2-tert-butyl-1, 3-thiazol-4-yl]-2-fluorophenyl]-2 and 6-difluorobenzenesulfonamide;methanesulfonic acid
InChI=1S/C23H20F3N5O2S2.CH4O3S/c1-23(2,3)21-30-18(19(34-21)16-10-11-28-22(27)29-16)12-6-4-9-15(17(12)26)31-35(32,33)20-13(24)7-5-8-14(20)25;1-5(2,3)4/h4-11,31H,1-3H3,(H2,27,28,29);1H3,(H,2,3,4)